Obesity Drugs in Development: A brief overview of the pipeline
November 30, 2021

Obesity and its causes are the focus of extensive research evaluating new therapeutic targets. Get an at-a-glance update on progress and FDA approvals during 2021

Bariatric Surgery Lowered Risk of Major Adverse Liver, CV Outcomes in NASH
November 29, 2021

In patients with biopsy-proven NASH, the SPLENDOR study is the first to report a medical modality associated with decreased risk of major adverse events.

Obesity Stigma in Clinical Practice: Ask Yourself these 8 Questions
November 23, 2021

Weight bias themes in primary care are the subject of contemporary research. Which options you choose to these 8 questions may offer insight into your own unconscious prejudices.

Primary Viewpoints Episode 12: Weight Stigma and Bias in Health Care
November 23, 2021

In our latest podcast episode, an obesity expert talks weight bias in health care, its widespread impact, and the advocacy work that is being done to change the narrative.

Confronting Weight Stigma in Primary Care: 10 Reports on the Problem & Strategies to Fix It
November 16, 2021

Weight bias or stigma in healthcare settings, whether explicit or implicit, may keep patients from getting care. Find a review of the recent literature in this slide show.

Semaglutide Demonstrates Significant Weight Loss, Improved Cardiometabolic Profile in Adults with Moderate-to-Severe Obesity
November 05, 2021

Semaglutide 2.4 mg led to clinically significant weight loss and improvements in cardiometabolic risk factors in adults with moderate or severe obesity, suggests new research from ObesityWeek 2021.

"Obesity is a Medically Approachable Problem" and Other Lessons with Lee Kaplan, MD, PhD
November 05, 2021

The evidence that obesity is pathophysiologic dysfunction in the human body places it squarely in the realm of chronic disease, according to obesity specialist Kaplan. Let’s treat it accordingly.

The Future of Obesity Medicine in Primary Care: A Conversation with Lee Kaplan, MD, PhD
November 04, 2021

Primary care leadership is essential to the future of obesity medicine, says Kaplan, but treatment needs to be within the normal scope of primary care practice. Hear him explain.

Obesity Treatment Pearls for Primary Care from Lee Kaplan, MD, PhD
November 04, 2021

Recognizing obesity as chronic pathophysiologic dysfunction and explaining that to a patient will make them remarkably more receptive to all other discussions about treatment, says obesity specialist Kaplan.

Semaglutide Superior to Liraglutide for Weight Loss in Head-to-Head Study
November 03, 2021

ObesityWeek 2021. Weight loss with semaglutide was more than 2 times greater than with liraglutide in the 68-week placebo-controlled trial of the 2 GLP-1 RAs.